Fig. 2 | Scientific Reports

Fig. 2

From: Integrative bioinformatics analysis identifies METTL1 as a regulator of immune infiltration and prognosis in breast cancer

Fig. 2

METTL1 highly expresses in breast invasive carcinoma patients. (a–b) The unpaired (a) and paired (b) analysis were performed using DESeq2 package to compare the METTL1 expression in BRCA and normal tissues. (c) The METTL1 expression in BRCA patients with age  65 years or > 65 years. (d) The METTL1 expression in BRCA patients with Stage I-II or Stage III-IV. (e) The ROC curve of METTL1 in BRCA patients was performed using ROCR package. BRCA, breast invasive carcinoma; ROC, receiver operating characteristic.

Back to article page